Christopher Hourigan

Associate Professor

20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher Hourigan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Residual Neoplasm Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Homologous Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

Lynes, J., Jackson, S., Sanchez, V., Dominah, G., Wang, X., Kuek, A., Hayes, C. P., Benzo, S., Scott, G. C., Chittiboina, P., Zaghloul, K. A., Park, D. M., Wu, J., Hourigan, C., Giles, A. J., Wu, T., Maric, D., Chen, J., Quezado, M., Heiss, J. D. & 2 others, Gilbert, M. R. & Nduom, E. K., Apr 1 2019, In : Neurosurgery. 84, 4, p. 945-953 9 p.

Research output: Contribution to journalArticle

Open Access
Immunologic Monitoring
Microdialysis
Glioblastoma
Cytokines
Lymphocyte Activation

Heterogeneity in refractory acute myeloid leukemia

Horibata, S., Gui, G., Lack, J., DeStefano, C. B., Gottesman, M. M. & Hourigan, C., Jan 1 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 21, p. 10494-10503 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Survival
RNA Sequence Analysis
Therapeutics
Gene Expression Profiling

Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab

Lai, C., Ranpura, V., Wu, C., Olnes, M. J., Parikh, A. R., Shenoy, A., Thompson, J., Weinstein, B., Scheinberg, P., John Barrett, A., Desmond, R., Young, N. S. & Hourigan, C. S., Apr 9 2019, In : Blood Advances. 3, 7, p. 980-983 4 p.

Research output: Contribution to journalLetter

Open Access
Myelodysplastic Syndromes
alemtuzumab

MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations

McReynolds, L. J., Yang, Y., Yuen Wong, H., Tang, J., Zhang, Y., Mulé, M. P., Daub, J., Palmer, C., Foruraghi, L., Liu, Q., Zhu, J., Wang, W., West, R. R., Yohe, M. E., Hsu, A. P., Hickstein, D. D., Townsley, D. M., Holland, S. M., Calvo, K. R. & Hourigan, C., Jan 1 2019, In : Leukemia Research. 76, p. 70-75 6 p.

Research output: Contribution to journalArticle

Germ-Line Mutation
Bone Marrow
Mutation
Bone Marrow Diseases
Leukemia, Myelomonocytic, Chronic

Molecular measurable residual disease testing of blood during AML cytotoxic therapy for early prediction of clinical response

Wong, H. Y., Sung, A. D., Lindblad, K. E., Sheela, S., Roloff, G. W., Rizzieri, D., Goswami, M., Mulé, M. P., Ramos, N. R., Tang, J., Thompson, J., DeStefano, C. B., Romero, K., Dillon, L. W., Kim, D. Y., Lai, C. & Hourigan, C., Jan 1 2019, In : Frontiers in Oncology. 9, JAN, 669.

Research output: Contribution to journalArticle

Open Access
Hematologic Diseases
Acute Myeloid Leukemia
Drug Therapy
Gene Frequency
Therapeutics